The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSDI Group Regulatory News (SDI)

Share Price Information for SDI Group (SDI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.00
Bid: 51.00
Ask: 53.00
Change: 0.00 (0.00%)
Spread: 2.00 (3.922%)
Open: 52.00
High: 52.00
Low: 51.50
Prev. Close: 52.00
SDI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Synbiosis Update

28 Jun 2010 07:00

RNS Number : 1395O
Scientific Digital Imaging Plc
28 June 2010
 



 

 

SCIENTIFIC DIGITAL IMAGING PLC

 

("SDI" or "The Group")

 

 

SYNBIOSIS INTRODUCES NEW IMAGING ACCESSORY, ProcUV,

AND

IMPROVEMENTS ARE MADE TO ProtoCOL2

 

SDI, the AIM quoted group focused on the needs of the scientific community, is pleased to update the market regarding recent developments at Synbiosis, a core division of SDI's principal subsidiary Synoptics Ltd. ("Synoptics"), a developer and manufacturer of innovative scientific instruments and systems that exploit digital imaging technology for a range of disciplines.

 

Highlights

 

·; ProtoCOL2 automated colony counter has been extensively tested to enable rapid, accurate counts of Legionella on any Legionella detection media

·; ProtoCOL2 upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotics susceptibility testing results

·; Synbiosis has introduced ProcUV, a new UV imaging accessory for the ProtoCOL2 system

 

 

At Synbiosis, the world-leading manufacturer of automated microbiological systems, the innovative ProtoCOL2 automated colony counter has been extensively tested by the Synbiosis technical team to enable rapid, accurate counts of Legionella on any Legionella detection media. The team found that by using the ProtoCOL2 system, 600Legionella plates could be accurately processed per hour, which is approximately 30 times more than can be achieved using traditional, time consuming, error-prone manual techniques.

 

The ProtoCOL2 has also been upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotics susceptibility testing results. The ProtoCOL2 software has also been upgraded so that numerical data can be automatically transferred into programmes for statistical analysis saving scientists valuable time and preventing transcription errors, as data can be transferred via a single button click rather than manually entered.

 

Additionally, Synbiosis has introduced ProcUV, its new ultra-violet imaging accessory for the ProtoCOL2 system. ProcUV permits instant imaging of fluorescent colonies and plaques so that they can be automatically counted or analysed by ProtoCOL2, thus saving time and improving accuracy of results.

 

ProcUV is simple to set up as its automatic exposure time settings ensure users can capture colony images at the touch of a button. The high-quality images can then be directly transferred into the ProtoCOL2 in seconds, where the ProtoCOL2 counts and analyses results automatically, to save microbiologists countless hours of repetitive work.

 

Commenting on the progress SDI's Chairman, Harry Tee, said:

 

"Synbiosis' progress with ProcUV and ProtoCOL2 demonstrates that we have risen to the challenge of rapid and accurate quantification of some of the most difficult-to-count colonies. We continue to look at new and innovative ways to improve our product offering to meet the needs of the scientific community."

 

 

 

--END--

 

 

FOR FURTHER INFORMATION

 

Scientific Digital Imaging plc 01223 727144

Harry Tee CBE, Chairman

Phil Atkin, CEO

www.scientificdigitalimaging.com 

 

Bishopsgate Communications 020 7562 3350

Gemma O'Hara

Siobhra Murphy

sdi@bishopsgatecommunications.com 

 

 

 

 

Note to Editors

 

 

Scientific Digital Imaging plc

 

SDI plc is focused on the application of digital imaging technology to the needs of the scientific community.

 

The principal subsidiary is Synoptics, which designs and manufactures special-purpose instruments for use in the life sciences. In October 2008 SDI acquired the entire share capital of Artemis and Perseu, companies (now known as "Atik") that design and manufacture high-sensitivity cameras for both astronomical and life sciences applications and whose products are used in instruments manufactured by Synoptics.

 

SDI, through its subsidiaries, offers a range of digital imaging solutions and intends to acquire other companies that are capable of contributing one or more key elements to the solutions required including an in-depth understanding of the applications in the marketplace, the ability to engineer complete systems to address such applications and the provision of key, high-performance components such as cameras.www.scientificdigitalimaging.com

 

 

Synoptics Ltd

 

Synoptics develops and manufactures innovative scientific instruments and systems that exploit digital imaging technology for a range of disciplines. Synoptics offers its products through 3 divisions.

 

·; Syngene - produces equipment for life scientists to image and analyse electrophoresis gels used for DNA and protein analysis.

·; Synbiosis - produces equipment for microbiologists to automate microbial colony counting.

·; Syncroscopy - provides systems which apply digital imaging techniques to microscopy applications, such as life and material sciences.

 

The Synoptics strategy is to deliver world-class, innovative products that satisfy the real needs of customers in science and industry. It does this by understanding their demands, and using its component technologies and skills in image processing and analysis to engineer appropriate solutions. The Company also seeks to exploit its unique technologies directly, by establishing OEM partnerships with other companies. www.synoptics.co.uk

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZXLFLBQFXBBD
Date   Source Headline
3rd Apr 20242:15 pmRNSExercise of Share Options and Total Voting Rights
18th Mar 202412:49 pmRNSHolding(s) in Company
18th Mar 20247:00 amRNSDirector/PDMR Shareholding
8th Mar 20243:15 pmRNSHolding(s) in Company
26th Feb 20247:00 amRNSLong Term Incentive Plan Awards
23rd Feb 202411:00 amRNSHolding(s) in Company
21st Feb 20246:00 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSHolding(s) in Company
13th Feb 202411:14 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSDirectorate Change – Appointment of New CEO
8th Dec 20233:45 pmRNSHolding(s) in Company
8th Dec 20232:30 pmRNSHolding(s) in Company
7th Dec 20231:15 pmRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSInterim Results
4th Dec 20237:00 amRNSNotice of Results and Investor Presentation
7th Nov 20234:10 pmRNSDirector/PDMR Shareholding
7th Nov 20233:50 pmRNSDirector/PDMR Shareholding and TVR - Replacement
7th Nov 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
6th Nov 20237:00 amRNSAcquisition of Peak Sensors
31st Oct 20234:20 pmRNSHolding(s) in Company
26th Oct 20235:45 pmRNSHolding(s) in Company
29th Sep 202311:30 amRNSResult of AGM
29th Sep 20237:00 amRNSAGM Trading Update
24th Aug 20237:00 amRNSBoard Appointment
8th Aug 20237:00 amRNSFinal Results
2nd Aug 20237:00 amRNSNotice of Results and Investor Presentation
26th May 20231:40 pmRNSHolding(s) in Company
16th May 20232:55 pmRNSHolding(s) in Company
11th May 202311:50 amRNSDirector Dealing
11th May 20237:00 amRNSTrading Update
19th Apr 20231:00 pmRNSDirector/PDMR Shareholding and TVR
12th Apr 20235:15 pmRNSDirector/PDMR Shareholding
31st Mar 20233:45 pmRNSDirector Dealing
15th Mar 202312:00 pmRNSHolding(s) in Company
15th Feb 20235:30 pmRNSHolding(s) in Company
13th Feb 20233:55 pmRNSHolding(s) in Company
3rd Feb 20232:00 pmRNSExercise of Options and Total Voting Rights
1st Feb 202310:15 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBoard Appointment
5th Jan 202310:00 amRNSExercise of Options and Total Voting Rights
14th Dec 20224:00 pmRNSExercise of Options and Total Voting Rights
7th Dec 20227:00 amRNSInterim Results
7th Nov 20227:00 amRNSInvestor Presentation
3rd Nov 20227:00 amRNSNotice of Results
27th Oct 20223:55 pmRNSDirector Dealings, Exercise of Options and TVR
26th Oct 20227:00 amRNSLong Term Incentive Plan Awards
24th Oct 20227:00 amRNSAcquisition of Fraser Anti-Static Techniques Ltd
21st Sep 20224:15 pmRNSResult of AGM and Board Appointment
21st Sep 20227:00 amRNSAGM Trading Update
24th Aug 20227:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.